A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

NCT01409135 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumors
Medical Oncology
Neoplasms

Interventions

DRUG: AGS-22M6E
DRUG: ASG-22CE

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]
[object Object]